RT Journal Article T1 Secondary hyperparathyroidism prevalence and profile, between diabetic and non-diabetic patients with stage 3 to 4 chronic kidney disease attended in internal medicine wards. MiPTH study A1 Arévalo-Lorido, José Carlos A1 Carretero Gómez, Juana A1 García Sánchez, Francisco Javier A1 Maciá Botejara, Enrique A1 Ramiro Lozano, José Manuel A1 Masero Carretero, Antonio A1 Roberto Robles, Nicolás A1 Bureo Dacal, Juan Carlos AB AimsSecondary hyperparathyroidism (SHPTH) is a leading cause of renal osteodystrophy, and an independent risk factor for all-cause and cardiovascular mortality. Our aim is to establish differences in prevalence and profile of SHPTH, regarding diabetics or non-diabetics with chronic kidney disease (CKD).MethodsCross-sectional multicenter study which included patients with stages 3 to 4 CKD. SHPTH was considered when the intact PTH levels (iPTH) were equal or higher than 70 pg/ml. We divided the sample into two groups (diabetics and non-diabetics). We used robust statistical methods.Results409 patients (214 diabetics) were studied. HPTH was found in 60.4% of diabetics vs 65% of non-diabetics (P = 0.42). Diabetics with HPTH were younger (79.5 vs 82.3 years-old, P = 0.005), and had more hypertension (P = 0.0014), dyslipidemia (P = 0.0001) and comorbidities. In multivariate analysis, we found a significant relationship in case of diabetics, with age (OR: 1.04, 95%CI 1.005–1.09 P = 0.02 ), and with statins treatment (OR 2.3, 95%CI 1.17–4.54, P = 0.01).DiscussionThe prevalence of SHPTH between the groups was similar, however, diabetics had more presence of hypertension and dyslipidemia, and SHPTH in this case was also related with moderate microalbuminuria and lower levels of vitamin D. An association with statins was also found in this group. PB Elsevier SN 1871-4021 YR 2016 FD 2016-04-15 LK https://hdl.handle.net/20.500.14352/122283 UL https://hdl.handle.net/20.500.14352/122283 LA spa NO Arévalo-Lorido, J. C., Carretero-Gómez, J., García-Sánchez, F., Maciá-Botejara, E., Ramiro-Lozano, J. M., Masero-Carretero, A., Robles, N. R., & Bureo-Dacal, J. C. (2016). Secondary hyperparathyroidism prevalence and profile, between diabetic and non-diabetic patients with stage 3 to 4 chronic kidney disease attended in internal medicine wards. MiPTH study. Diabetes & metabolic syndrome, 10(2 Suppl 1), S16–S21. https://doi.org/10.1016/j.dsx.2016.01.011 DS Docta Complutense RD 10 jul 2025